140410 — Mezzion Pharma Co Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareHighly SpeculativeMid CapMomentum Trap

Annual balance sheet for Mezzion Pharma Co, fiscal year end - December 31st, KRW millions except per share, conversion factor applied.

	2021 December 31st	2022 December 31st	2023 December 31st	2024 December 31st	2025 December 31st
Period Length:	—	—	—	—	—
Source:	Annual Audited Accounts	Annual Audited Accounts	Annual Audited Accounts	Annual Audited Accounts	Annual Audited Accounts
Standards:	IFRS	IFRS	IFRS	IFRS	IFRS
Status:	Final	Final	Final	Final	Final
Cash
Cash and Equivalents
Short Term Investments
Cash and Short Term Investments	47,210	32,399	58,246	28,617	25,574
Net Total Accounts Receivable
Net Total Receivables	4,591	4,363	6,031	1,757	2,121
Total Inventory
Prepaid Expenses
Total Other Current Assets
Total Current Assets	64,174	45,897	74,244	41,926	45,586
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	4,879	4,245	2,854	2,529	2,516
Net Intangible Assets
Long Term Investments
Long Term Notes Receivable
Other Long Term Assets
Total Assets	83,935	54,022	92,149	73,998	98,025
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities	18,497	26,080	29,615	26,670	79,572
Long Term Debt
Capital Lease Obligations
Total Long Term Debt
Total Debt
Deferred Income Tax
Total Other Liabilities
Total Funded Status
Total Liabilities	21,141	27,782	30,705	27,935	80,830
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
ESOP Debt Guarantee
Other Equity
Total Equity	62,793	26,240	61,444	46,063	17,195
Total Liabilities & Shareholders' Equity	83,935	54,022	92,149	73,998	98,025
Total Common Shares Outstanding